Chugai Pharmaceutical Statistics
Total Valuation
CHGCY has a market cap or net worth of 81.17 billion. The enterprise value is 74.79 billion.
| Market Cap | 81.17B |
| Enterprise Value | 74.79B |
Important Dates
The last earnings date was Thursday, April 24, 2025.
| Earnings Date | Apr 24, 2025 |
| Ex-Dividend Date | Jun 27, 2025 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.01% |
| Shares Change (QoQ) | -0.03% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 639.69M |
Valuation Ratios
The trailing PE ratio is 29.63.
| PE Ratio | 29.63 |
| Forward PE | n/a |
| PS Ratio | 9.95 |
| PB Ratio | 6.37 |
| P/TBV Ratio | 6.43 |
| P/FCF Ratio | 34.45 |
| P/OCF Ratio | 29.40 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 18.14, with an EV/FCF ratio of 31.74.
| EV / Earnings | 27.31 |
| EV / Sales | 9.06 |
| EV / EBITDA | 18.14 |
| EV / EBIT | 19.14 |
| EV / FCF | 31.74 |
Financial Position
The company has a current ratio of 7.28
| Current Ratio | 7.28 |
| Quick Ratio | 5.95 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 23.11% and return on invested capital (ROIC) is 20.38%.
| Return on Equity (ROE) | 23.11% |
| Return on Assets (ROA) | 17.92% |
| Return on Invested Capital (ROIC) | 20.38% |
| Return on Capital Employed (ROCE) | 29.97% |
| Revenue Per Employee | 1.62M |
| Profits Per Employee | 544,953 |
| Employee Count | 5,026 |
| Asset Turnover | 0.61 |
| Inventory Turnover | 1.39 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +69.81% in the last 52 weeks. The beta is 0.76, so CHGCY's price volatility has been lower than the market average.
| Beta (5Y) | 0.76 |
| 52-Week Price Change | +69.81% |
| 50-Day Moving Average | 25.12 |
| 200-Day Moving Average | 23.37 |
| Relative Strength Index (RSI) | 47.54 |
| Average Volume (20 Days) | 154,560 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, CHGCY had revenue of 8.16 billion and earned 2.74 billion in profits. Earnings per share was 1.66.
| Revenue | 8.16B |
| Gross Profit | 5.80B |
| Operating Income | 3.87B |
| Pretax Income | 3.87B |
| Net Income | 2.74B |
| EBITDA | 4.04B |
| EBIT | 3.87B |
| Earnings Per Share (EPS) | 1.66 |
Balance Sheet
The company has 6.31 billion in cash and n/a in debt, giving a net cash position of 6.31 billion.
| Cash & Cash Equivalents | 6.31B |
| Total Debt | n/a |
| Net Cash | 6.31B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 12.74B |
| Book Value Per Share | 7.74 |
| Working Capital | 8.73B |
Cash Flow
In the last 12 months, operating cash flow was 2.76 billion and capital expenditures -404.37 million, giving a free cash flow of 2.36 billion.
| Operating Cash Flow | 2.76B |
| Capital Expenditures | -404.37M |
| Free Cash Flow | 2.36B |
| FCF Per Share | n/a |
Margins
Gross margin is 71.01%, with operating and profit margins of 47.36% and 33.56%.
| Gross Margin | 71.01% |
| Operating Margin | 47.36% |
| Pretax Margin | 47.37% |
| Profit Margin | 33.56% |
| EBITDA Margin | 49.52% |
| EBIT Margin | 47.36% |
| FCF Margin | 28.87% |
Dividends & Yields
This stock pays an annual dividend of 1.22, which amounts to a dividend yield of 4.34%.
| Dividend Per Share | 1.22 |
| Dividend Yield | 4.34% |
| Dividend Growth (YoY) | 127.10% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 39.42% |
| Buyback Yield | -0.01% |
| Shareholder Yield | 4.33% |
| Earnings Yield | 3.37% |
| FCF Yield | 2.90% |
Stock Splits
The last stock split was on July 6, 2020. It was a forward split with a ratio of 12.
| Last Split Date | Jul 6, 2020 |
| Split Type | Forward |
| Split Ratio | 12 |
Scores
CHGCY has an Altman Z-Score of 30.4.
| Altman Z-Score | 30.4 |
| Piotroski F-Score | n/a |